Filing Flows

Filing Flows › Aspen Aerogels (ASPN) › Guidance & outlook

Aspen Aerogels (ASPN) guidance and outlook

Aspen Aerogels (ASPN) initiated its guidance on Nov 5, 2026: Revenue $60.0M–$75.0M for Q4 2026; Net income $8.0M–$11.0M for Q4 2026; EPS $0.10–$0.13 for Q4 2026; EBITDA $5.0M–$13.0M for Q4 2026. Aspen Aerogels' 10-Q filed Nov 5, 2026 makes 25 forward-looking statements.

Guidance and outlook

Aspen Aerogels Revenue: guidance against what was reportedAspen Aerogels Revenue: guidance against what was reportedguided rangereported (above / within / below)Q2 2026$49.8MQ3 2026$85.2MQ4 2026
Met or beat 2 of 2 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.
Aspen Aerogels: what its forward-looking statements are about (10-Q filed 2026-11-05)Aspen Aerogels: what its forward-looking statements are about (10-Q filed 2026-11-05)Demand10Other7Costs4Capital spending2Financing1Margins1
25 statements; tone -0.20 (−1 all cautious, +1 all confident); 1 hedged.
Aspen Aerogels: outlook statements against the filing beforeAspen Aerogels: outlook statements against the filing beforeConfident5Cautious10

Latest guidance

MetricPeriodRangeChange
RevenueQ4 2026$60.0M–$75.0Mnew
Net incomeQ4 2026$8.0M–$11.0Mnew
EPSQ4 2026$0.10–$0.13new
EBITDAQ4 2026$5.0M–$13.0Mnew
Capital expendituresFY2026$10.0Mnew
Depreciation & amortizationQ4 2026$5.0Mnew
Stock-based compensationQ4 2026$3.0Mnew
Interest expenseQ4 2026$3.0Mnew
Net incomethe quarter ending Dec 31, 2026−$11.0Mnew
Depreciation & amortizationthe quarter ending Dec 31, 2026$5.0Mnew
Stock-based compensationthe quarter ending Dec 31, 2026$3.0Mnew
Other incomethe quarter ending Dec 31, 2026$3.0Mnew

From the earnings release filed Nov 5, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 5, 2026

Aspen Aerogels' latest quarter

Aspen Aerogels, Q3 2026: revenue $85.2M (+17% year over year), operating margin -8.4%, net loss $10.4M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.

Questions

Did Aspen Aerogels raise or lower its guidance?

Aspen Aerogels (ASPN) initiated its guidance on Nov 5, 2026: Revenue $60.0M–$75.0M for Q4 2026; Net income $8.0M–$11.0M for Q4 2026; EPS $0.10–$0.13 for Q4 2026; EBITDA $5.0M–$13.0M for Q4 2026.

What does Aspen Aerogels expect?

We believe we will have additional opportunities to address high-value applications in the global insulation market, as well as in adjacent market opportunities such as energy storage applications, including battery energy storage systems, electrification applications, and other potential adjacent applications subject to their commercial potential, the differentiation of our products, and the ability to leverage… Our technologically advanced insulation products are targeted at the multi-billion dollar global market for energy industrial insulation materials. We have grown our business by formi

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.